1-11 of 11
Marlise R. Luskin
Close
Sort by
Journal Articles

Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survival

Shai Shimony, Julia Keating, Christopher J. Fay, Marlise R. Luskin, Donna S. Neuberg, Nicole R. LeBoeuf, Andrew A. Lane
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2803–2812.
https://doi.org/10.1182/bloodadvances.2024012797
Published: 2024
Includes: Supplemental data
Journal Articles

Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia

Clinical Trials & Observations
Andrew A. Lane, Jacqueline S. Garcia, Evangeline G. Raulston, Jada L. Garzon, Ilene Galinsky, Emilie W. Baxter, Rebecca Leonard, Daniel J. DeAngelo, Marlise R. Luskin, Christopher R. Reilly, Maximilian Stahl, Richard M. Stone, Rahul S. Vedula, Martha M. Wadleigh, Eric S. Winer, Tariq Mughal, Christopher Brooks, Ira V. Gupta, Kristen E. Stevenson, Donna S. Neuberg, Siyang Ren, Julia Keating, Marina Konopleva, Anthony Stein, Naveen Pemmaraju
Journal: Blood Advances
Blood Adv (2024) 8 (3): 591–602.
https://doi.org/10.1182/bloodadvances.2023011721
Published: 2024
Includes: Supplemental data
Journal Articles

Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia

Shai Shimony, Daniel J. DeAngelo, Marlise R. Luskin
Journal: Blood Advances
Blood Adv (2023) 8 (1): 23–36.
https://doi.org/10.1182/bloodadvances.2023010303
Published: 2023
Journal Articles

FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years

Clinical Trials & Observations
Shai Shimony, Geoffrey Fell, Evan C. Chen, Harrison K. Tsai, Martha Wadleigh, Eric S. Winer, Jacqueline S. Garcia, Marlise R. Luskin, Maximilian Stahl, Donna S. Neuberg, Daniel J. DeAngelo, R. Coleman Lindsley, Richard M. Stone
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5354–5358.
https://doi.org/10.1182/bloodadvances.2023009748
Published: 2023
Includes: Supplemental data
Journal Articles

Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials

Clinical Trials & Observations
Shai Shimony, Yael Flamand, Yannis K. Valtis, Andrew E. Place, Lewis B. Silverman, Lynda M. Vrooman, Andrew M. Brunner, Stephen E. Sallan, Richard M. Stone, Martha Wadleigh, Donna S. Neuberg, Daniel J. DeAngelo, Marlise R. Luskin
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5234–5245.
https://doi.org/10.1182/bloodadvances.2023009976
Published: 2023
Includes: Supplemental data
Journal Articles

Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia

Clinical Trials & Observations
Shai Shimony, Yiwen Liu, Yannis K. Valtis, Jonathan D. Paolino, Andrew E. Place, Andrew M. Brunner, Lachelle D. Weeks, Lewis B. Silverman, Lynda M. Vrooman, Donna S. Neuberg, Richard M. Stone, Daniel J. DeAngelo, Marlise R. Luskin
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1092–1102.
https://doi.org/10.1182/bloodadvances.2022008280
Published: 2023
Includes: Supplemental data
Journal Articles

Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy

Jurjen Versluis, Manu Pandey, Yael Flamand, J. Erika Haydu, Roger Belizaire, Mark Faber, Rahul S. Vedula, Anne Charles, Kevin M. Copson, Shai Shimony, Alon Rozental, Pavan K. Bendapudi, Ofir Wolach, Elizabeth A. Griffiths, James E. Thompson, Richard M. Stone, Daniel J. DeAngelo, Donna Neuberg, Marlise R. Luskin, Eunice S. Wang, R. Coleman Lindsley
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2835–2846.
https://doi.org/10.1182/bloodadvances.2021006166
Published: 2022
Includes: Supplemental data
Journal Articles

t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity

Sarah B. Mueller, Paola Dal Cin, Long P. Le, Dora Dias-Santagata, Jochen K. Lennerz, A. John Iafrate, Hetal Desai Marble, Andrew M. Brunner, Matthew J. Weinstock, Marlise R. Luskin, Daniel J. De Angelo, Richard M. Stone, Valentina Nardi
Journal: Blood Advances
Blood Adv (2022) 6 (3): 818–827.
https://doi.org/10.1182/bloodadvances.2021005280
Published: 2022
Includes: Supplemental data
Journal Articles

Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium Trials

Clinical Trials & Observations
Yannis K. Valtis, Kristen E. Stevenson, Andrew E. Place, Lewis B. Silverman, Lynda M. Vrooman, Giacomo Gotti, Andrew M. Brunner, Mary Nauffal, Daniel J. DeAngelo, Marlise R. Luskin
Journal: Blood Advances
Blood Adv (2021) 6 (1): 72–81.
https://doi.org/10.1182/bloodadvances.2021005278
Published: 2021
Includes: Supplemental data
Journal Articles

Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials

Clinical Trials & Observations
Andrew Hantel, Marlise R. Luskin, Jacqueline S. Garcia, Wendy Stock, Daniel J. DeAngelo, Gregory A. Abel
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4352–4360.
https://doi.org/10.1182/bloodadvances.2021005148
Published: 2021
Includes: Supplemental data
Journal Articles

Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screening

Clinical Trials & Observations
Marlise R. Luskin, Marie N. Discenza, Sarah Rae Easter, Paola Dal Cin, Renius Owen, Bernard Ilagan, Meredith Masiello, Andrew A. Lane
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1491–1494.
https://doi.org/10.1182/bloodadvances.2017008680
Published: 2017